Search Within

Maria Perry

Formats
  1. Journal Article (3)
  2. Meeting Abstract (3)
Groups
  1. CTCR Scholars (6)
  2. Department of Medicine (6)
  3. GSK Faculty (6)
  4. Human Oncology and Pathogenesis Program (6)
  5. Solid Tumor Oncology Division (6)
  6. Center for Pancreatic Cancer Research (5)

More Groups

People
  1. Eileen O'Reilly (5)
  2. Wungki Park (5)
  3. Chaitanya Bandlamudi (4)
  4. Anna Varghese (3)
  5. Catherine O'Connor (3)
  6. David Solit (3)

More People

Years
  1. 2025 (2)
  2. 2024 (3)
  3. 2023 (1)
Publications
  1. Journal of Clinical Oncology (3)
  2. Cell (1)
  3. JNCI: Journal of the National Cancer Institute (1)
  4. Nature (1)
Publishers
  1. American Society of Clinical Oncology (3)
  2. Cell Press (1)
  3. Nature Publishing Group (1)
  4. Oxford University Press (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Adjuvant modified FOLFIRINOX for resected pancreatic adenocarcinoma: Clinical insights and genomic features from a large contemporary cohort
    Journal Article

    Keane, F.; O’Connor, C.; Moss, D.; Chou, J. F.; Perry, M. A.; Crowley, F.; Saxena, P.; Chan, A.; Schoenfeld, J. D.; Singhal, A.; more...
    JNCI: Journal of the National Cancer Institute (2025)

    Fulltext@MSK | Save
  • Pan-cancer analysis of biallelic inactivation in tumor suppressor genes identifies KEAP1 zygosity as a predictive biomarker in lung cancer
    Journal Article

    Zucker, M.; Perry, M. A.; Gould, S. I.; Elkrief, A.; Safonov, A.; Thummalapalli, R.; Mehine, M.; Chakravarty, D.; Brannon, A. R.; Ladanyi, M.; more...
    Cell (2025)

    Fulltext@MSK | Save
  • Automated real-world data integration improves cancer outcome prediction
    Journal Article

    Jee, J.; Fong, C.; Pichotta, K.; Tran, T. N.; Luthra, A.; Waters, M.; Fu, C.; Altoe, M.; Liu, S. Y.; Maron, S. B.; more...
    Nature (2024)

    Fulltext@MSK | Save
  • Durvalumab and stereotactic ablative body radiotherapy (SABR) in locally advanced (LA) and borderline resectable (BR) pancreatic cancer (PDAC): Long-term outcomes and correlative insights
    Meeting Abstract

    Keane, F.; Tuli, R.; O'Connor, C. A.; Schwartz, C.; Park, W.; Varghese, A. M.; Perry, M.; Singhal, A.; Vardhana, S.; Hendifar, A. E.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Adjuvant mFOLFIRINOX (mFFX) for resected pancreatic cancer (PC): Long term clinical and genomic outcomes
    Meeting Abstract

    Keane, F.; Moss, D.; O'Connor, C. A.; Perry, M.; Chou, J. F.; Crowley, F.; Saxena, P.; Chan, A.; Park, W.; Varghese, A. M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Clinical outcomes for IDH1 mutant biliary tract cancer (BTC) treated with contemporary systemic therapy
    Meeting Abstract

    Cowzer, D.; Huq, R.; Perry, M.; Keane, F.; Park, W.; El Dika, I. H.; Khalil, D.; Shia, J.; Sigel, C. S.; Bandlamudi, C.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save